Visceral adiposity index (VAI) is predictive of an altered adipokine profile in patients with type 2 diabetes.
about
The role of metabolic syndrome in heart failureResistin's, obesity and insulin resistance: the continuing disconnect between rodents and humans.Visceral adiposity index: an indicator of adipose tissue dysfunction.The Role of the Growth Hormone/Insulin-Like Growth Factor System in Visceral Adiposity.Quantification and regulation of adipsin in human cerebrospinal fluid (CSF).Diabetes mellitus and ovarian cancer: more complex than just increasing riskExercise protects against obesity induced semen abnormalities via downregulating stem cell factor, upregulating Ghrelin and normalizing oxidative stressSensitivity of various adiposity indices in identifying cardiometabolic diseases in Arab adults.Visceral fat dysfunction is positively associated with hypogonadism in Chinese men.Effect of orlistat alone or in combination with Garcinia cambogia on visceral adiposity index in obese patients.Association of body composition assessed by bioelectrical impedance analysis with metabolic risk factor clustering among middle-aged Chinese.Visceral adiposity index as a predictor of clinical severity and therapeutic outcome of PCOS.Visceral adiposity index as an indicator of cardiometabolic risk in patients treated for craniopharyngioma.Reciprocal changes of serum adispin and visfatin levels in patients with type 2 diabetes after an overnight fast.Human resistin and the RELM of Inflammation in diabesity.Liraglutide Improves Cardiovascular Risk as an Add-on to Metformin and Not to Insulin Secretagogues in Type 2 Diabetic Patients: A Real-life 48-Month Retrospective Study.Antiplatelets and profibrinolytic activity of Citrullus colocynthis in control and high-fat diet-induced obese rats: mechanisms of action.Body Adiposity Index, but not Visceral Adiposity Index, Correlates with Inflammatory Markers in Sarcopenic Obese Elderly Women.Effect of Gum Arabic (Acacia Senegal) supplementation on visceral adiposity index (VAI) and blood pressure in patients with type 2 diabetes mellitus as indicators of cardiovascular disease (CVD): a randomized and placebo-controlled clinical trial.Obesity treatment by very low-calorie-ketogenic diet at two years: reduction in visceral fat and on the burden of disease.Gastric bypass simultaneously improves adipose tissue function and insulin-dependent type 2 diabetes mellitus.Visceral adiposity index levels in overweight and/or obese, and non-obese patients with polycystic ovary syndrome and its relationship with metabolic and inflammatory parameters.Higher cardiometabolic risk in idiopathic versus autoimmune type 1 diabetes: a retrospective analysis.LH/FSH Ratio Is Associated With Visceral Adipose Dysfunction in Chinese Women Older Than 55
P2860
Q28085668-1B7F7F68-9D7A-4F30-8EDC-E0F00BADF759Q30382436-E9398117-2143-45C2-A034-6ABFC2F149DCQ33563343-53F4AC10-FAC2-47DA-9798-69DCD055B0D5Q33602919-DA39C29C-148C-4EDB-B49D-489FC22B74F9Q34485611-F117C9A4-70C5-4D9D-B30E-A99BA03D165BQ34615282-22AB5DA2-64E5-41A1-A097-71C0CB29FE4AQ35729223-0FDC8F49-B672-41A6-826B-204E91B89A6DQ36051230-7A897EF8-2A54-42FA-91ED-A3E7909A6DD7Q36500366-B48150F1-8967-4828-8A2F-1092E1A27E1CQ37334443-F7D45EEC-1E88-463E-8B51-7C9AE14EE53FQ37725241-D6188558-E9C9-40D0-BDBB-B7057F19A138Q38616584-1B776F91-944B-498B-A4BB-00CC13E65482Q39096101-C678AF56-E25A-463F-A5A6-07EE061DDCAAQ39973379-2C20DEFB-2C01-49DC-9921-B53C9D9A1C57Q42416828-23C8C03E-A27C-442A-A022-9FAF24B9081AQ47594612-19A5D35F-6A22-4760-B78A-70509015C0EAQ50249036-996D7788-F175-442A-AB9D-4162F8B01FAFQ51081016-77D4BFD5-0575-4864-942A-A83485C4888CQ51244819-F86FC982-1FC7-4E6A-859F-E64B6545840FQ51511659-B48E39DC-474F-4566-BDF9-91FBFFC9250BQ53733510-0ADA4676-EFDB-4FF5-8263-4FC2833CD941Q53761370-E51DA835-2BFD-486E-BABB-760F2E75B8AFQ55235309-754F16B4-EDC2-4663-B8E3-02302C3D7128Q58803358-4F63462F-48E2-4AC5-8F19-CCE9079B1B99
P2860
Visceral adiposity index (VAI) is predictive of an altered adipokine profile in patients with type 2 diabetes.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Visceral adiposity index (VAI) ...... patients with type 2 diabetes.
@ast
Visceral adiposity index (VAI) ...... patients with type 2 diabetes.
@en
type
label
Visceral adiposity index (VAI) ...... patients with type 2 diabetes.
@ast
Visceral adiposity index (VAI) ...... patients with type 2 diabetes.
@en
prefLabel
Visceral adiposity index (VAI) ...... patients with type 2 diabetes.
@ast
Visceral adiposity index (VAI) ...... patients with type 2 diabetes.
@en
P2093
P2860
P1433
P1476
Visceral adiposity index (VAI) ...... patients with type 2 diabetes.
@en
P2093
Gabriella Misiano
Marco C Amato
Salvatore Milano
Vittoria Torregrossa
P2860
P304
P356
10.1371/JOURNAL.PONE.0091969
P407
P577
2014-03-20T00:00:00Z